stockrowNeogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Return on assets
Neogen Corporation's return on assets over the twelve months to 31 August 2026 was −1.68%, down 1.4 percentage points from fiscal 2026 (−0.23%). Over the past ten years it has ranged from −27.3% (fiscal 2025) to 11.0% (fiscal 2018); the current reading is higher than 25% of that period. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | −0.23% | 27.10 |
| FY2025 | −27.3% | (27.12) |
| FY2024 | −0.21% | 0.61 |
| FY2023 | −0.82% | (5.87) |
| FY2022 | 5.05% | (2.04) |
| FY2021 | 7.09% | (0.88) |
| FY2020 | 7.97% | (1.19) |
| FY2019 | 9.16% | (1.86) |
| FY2018 | 11.0% | 2.07 |
| FY2017 | 8.95% | 0.27 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| TMDX TransMedics Group, Inc. compare | 11.7% |
| UFPT UFP Technologies, Inc. compare | 11.5% |
| INSP Inspire Medical Systems, Inc. compare | 11.4% |
| ITGR Integer Holdings Corporation compare | 3.05% |
| NEOG Neogen Corporation | −1.68% |
| AXGN AxoGen, Inc. compare | −8.33% |
| ESTA Establishment Labs Holdings Inc. compare | −11.4% |
| BFLY Butterfly Network, Inc. compare | −18.6% |
| ALMR Alamar Biosciences, Inc. compare | −20.8% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement